|
|
Solos Endoscopy , Inc. is a healthcare
technology company whose mission is to develop and market breakthrough
technology, applications, medical devices, and procedural techniques
for the screening, diagnosis, treatment and management of disease
and medical conditions. Backed by technical support, Solos' sales
team can help make the right buying decisions for the hospital,
surgery center, or physician office.
Solos Endoscopy, Inc. Letter to Shareholders (December 2009)
Current Operations
Solos' has extensive relationships with contract manufacturers for its current products. It maintains customer service and warehousing at its 8,000sqft facility in Boston , MA.
Products
The Company has developed products that have enhanced the ability to perform
minimally invasive surgical techniques. Products range from complete video
systems to specialized hand held instruments.
Offices
Solos Endoscopy Inc's principal office is located
at 65 Sprauge St., Boston, MA 02136 USA. Phone: 1-800-388-6445. |
 |
|
 |
|
|
|
|
Investor
FAQs |
|
|
|
|
|
When was Solos Endoscopy, Inc. incorporated?
Solos Endoscopy, Inc. (Solos Endoscopy) was incorporated April 16, 1986
in Nevada, under the name Solos Endoscopy, Inc.
When did Solos Endoscopy go public?
In April of 2006, Solos Endoscopy announced that the Company has gone
public through a merger with ViaDux Healthcare, a public company (VDXH).
Where are Solos Endoscopy's corporate headquarters located?
The company's headquarters are currently located in Boston, MA.
When does Solos Endoscopy's fiscal year end?
Solos Endoscopy's fiscal year ends on December 31.
Does Solos Endoscopy, Inc.'s report the company' financial results publicly?
No, currently Solos Endoscopy does not file its financials
with the Securities and Exchange Commission ( www.sec.gov ).
What industry is Solos Endoscopy in?
Solos Endoscopy is involved in the following industries: Biotechnology,
Medical Devices, Health Care, Research and Science.
What is Solos Endoscopy's primary business?
Solos Endoscopy , Inc. is a healthcare technology company whose mission is
to develop and market breakthrough technology, applications, medical devices,
and procedural techniques for the screening, diagnosis, treatment and management
of disease and medical conditions. Solos' offers state-of-the-art
color video camera systems, minimally invasive
surgical instrumentation and accessories.
How do I invest in Solos Endoscopy?
You may purchase Solos Endoscopy's common stock from any NASD member
broker/dealer, including discount or online brokerage services.
On what stock exchange is Solos Endoscopy listed?
Solos Endoscopy trades on the Pink Sheets under the symbol
SNDY.
What is Solos Endoscopy's CUSIP Number?
834371-10-6
Does Solos Endoscopy pay dividends?
No, all resources are being channeled into product marketing and development.
Who do I contact in case of a lost or missing stock certificate?
Florida Atlantic Stock Transfer, Inc.
7130 Nob Hill Road
Tamarac, FL 33321
Phone: (954) 726-4954
Fax: (954) 726-6305 |
|
|
|
|
|
|
|
|
|
|
Financial
Information |
|
|
|
|
|
There are no financial reports available at this time. |
|
|
|
| |
|
|
|
|
|
|
|
|
Press
Releases |
|
|
|
|
|
Dec 9, 2009 Solos Endoscopy, Inc. Reports Sales Increase for October 2009 and November 2009 as Compared to Same Two Months in 2008
Nov 11, 2009 Solos Endoscopy, Inc.'s Breast Endoscopy System Featured in November Issue of Healthcare Purchasing News Magazine
Thu, Nov 5, 2009 Solos Endoscopy, Inc. Has Retained Services of Experienced Medical Marketing Firm for a 2010 Campaign
Tue, Nov 3, 2009 Solos Endoscopy, Inc. Receives Purchase Orders from Catholic Health Initiatives for its MammoView(TM) Product Line
Thu, Oct 29, 2009 Solos Endoscopy, Inc. Receives Purchase Orders from University of California, San Diego Medical Center for its MammoView(TM) Product Line
Tue, Oct 27, 2009 Solos Endoscopy, Inc. Receives Purchase Orders from BJC HealthCare for its MammoView(TM) Product Line
|
|
|
|
| |
|
|
|
|
|
|
|
|
Legal - Safe Harbor |
|
|
|
|
|
This, the Solos Endoscopy, Inc. ( www.solosendoscopy.com )
website contains forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. In particular, when used in this
website, the words “believe,” “expects,” “intends,” “will,” “anticipates,” “anticipated,” or “may,” and
similar conditional expressions are intended to identify forward-looking statements
within the meaning of the Act and are subject to the safe harbor created by
the Act. Except for historical information, all of the statements, expectations
and assumptions contained in this website are forward-looking that involve
a number of risks and uncertainties, including, but not limited to, certain
delays beyond the Company's control with respect to market acceptance of new
technologies or products; delays in testing and evaluation of products; FDA
clearance; business conditions and the amount of growth in the Company's industry
and general economy; competitive factors; ability to attract and retain personnel;
the ability to attract and obtain adequate financing; the price of the Company's
stock; and other factors and risks. The Company takes no obligation to update
or correct forward-looking statements or information on this website. |
|
|
|
| |
|
|
|
|
|
|
